Biodesix – pharmaceutical daily

May 19, 2020 Off

Biodesix Collaborates With Bio-Rad to Launch a Serology Test to Detect Coronavirus (COVID-19) Antibodies

Biodesix, Bio-Rad will launch a blood-based immunoassay-based test that identifies antibodies to SARS-CoV-2, the virus that causes COVID-19.

September 23, 2019 Off

Biodesix Highlights Pipeline and Companion Diagnostic Development at World CDx and RAS-Targeted Drug Discovery

By BusinessWire

Case Study Based Review of Companion Diagnostic (CDx) Capabilities and Importance of Monitoring KRAS mutations BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. today…

September 18, 2019 Off

Biodesix new clinical data shows VeriStrat testing predicts survival in advanced NSCLC and immunotherapy

By BusinessWire

Biodesix’s positive Results from Multiple Studies Support Clinical Utility of VeriStrat Testing